+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Fibrinogen longmont: A dysfibrinogenemia that causes prolonged clot-based test results only when using an optical detection method



Fibrinogen longmont: A dysfibrinogenemia that causes prolonged clot-based test results only when using an optical detection method



American Journal of Hematology 63(3): 149-155



A new fibrinogen variant was discovered as a result of discrepancies found in routine laboratory screening. The patient, a healthy 37-year-old woman, had a mild bleeding history. Initial coagulation studies on the patient revealed a prolonged prothrombin time (PT) and a normal activated partial thromboplastin time (APTT). Further investigation on the patient and her mother demonstrated both had a PT with no end point using an optical detection method (ACL3000+) and a normal PT using an electromechanical detection method (ST4 Clot Detection System). The APTT for both the patient and her mother were essentially normal with both optical and mechanical detection methods. The patient and her mother also had markedly prolonged thrombin time and reptilase time results on the ACL3000+, but they were normal on the ST4. Coagulation test results on the patient's father were all normal. We believe the fibrinogen defect in this family may affect fibrin polymerization only enough to effect light scatter interpretation, while there is enough polymerization to increase plasma viscosity and yield an end point using an electromechanical analyzer. This report should alert pathologists and clinicians to possible discrepancies between mechanical and spectrophotometric clot testing methods.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 010663167

Download citation: RISBibTeXText

PMID: 10679806

DOI: 10.1002/(sici)1096-8652(200003)63:3<149::aid-ajh8>3.0.co;2-#


Related references

Fibrinogen Krakow: a novel hypo/dysfibrinogenemia mutation in fibrinogen gamma chain (Asn325Ile) affecting fibrin clot structure and function. Thrombosis and Haemostasis 101(5): 975-976, 2009

Thrombotic dysfibrinogenemia: Fibrinogen Caracas V relation between very tight fibrin network and defective clot degradability. Thrombosis Research 99(2): 187-193, 2000

How to deal with samples with errors on Aptt, Pt and fibrinogen due to optical clot detection?. Clinica Chimica Acta 493: S391-S392, 2019

Analysis of plasmin generation and clot lysis of plasma fibrinogen purified from a heterozygous dysfibrinogenemia, BbetaGly15Cys (Hamamatsu II). Blood Coagulation and Fibrinolysis 20(8): 726-732, 2009

Comparison of the fibrinogen Clauss assay and the fibrinogen PT derived method in patients with dysfibrinogenemia. Thrombosis Research 126(6): E428-E433, 2010

A kinetic method for characterization of heterogenous fibrinogen and its application to fibrinogen Grand Rapids, a congenital dysfibrinogenemia. Thrombosis and Haemostasis 48(2): 182-186, 1982

Fibrinogen Longmont. A heterozygous abnormal fibrinogen with B beta Arg-166 to Cys substitution associated with defective fibrin polymerization. Annals of the new York Academy of Sciences 936: 129-132, 2001

Bleeding tendency and prolonged wound healing in a patient with A alphaArg16His dysfibrinogenemia: fibrinogen Krakow IV. Thrombosis Research 129(4): 532-533, 2012

Comparison of the kinetic fibrinogen assay with the von Clauss method and the clot recovery method in plasma of patients with conditions affecting fibrinogen coagulability. American Journal of Clinical Pathology 104(4): 455-462, 1995

An experimental clot model in sheep; generation of a heterologous clot and its detection in vivo using venography and (125)I labelled fibrinogen. Research in Veterinary Science 72(3): 217-221, 2002

Dextran and hydroxyethyl starch do not interfere with fibrinogen measurement if Clauss method with a mechanical clot detection is used. 2011

Dextran and hydroxyethyl starch do not interfere with fibrinogen measurement if Clauss method with mechanical clot detection is used. Critical Care 15(5): 441, 2011

Fibrin assembly of the homozygous dysfibrinogenemia Fibrinogen Metz depends solely on B-beta interaction Fibrin ultra structure and clot physical properties A possible explanation for mild bleeding tendency. Blood Coagulation & Fibrinolysis 9(7): 700, 1998

Results of an activated microtitre clot lysis assay in plasma from individuals with hypo-/dysplasminogenemia and dysfibrinogenemia. Fibrinolysis 8(Suppl. 1): 47, 1994

A novel mutation (deletion of Aalpha-Asn 80) in an abnormal fibrinogen: fibrinogen Caracas VI. Consequences of disruption of the coiled coil for the polymerization of fibrin: peculiar clot structure and diminished stiffness of the clot. Blood Coagulation & Fibrinolysis 15(7): 559-567, 2004